Skip to main content
Caplight Logo









Graviton BioScience

Graviton BioScience

Private
New York City, New YorkHealthcare & Life Scienceshttps://graviton.bio/

Last Round

Series B

Feb 14, 2024

Est. Valuation

$255M

Total Funding Raised

$63.5M

Company Overview

Graviton BioScience is a biotechnology company that discovers and develops innovative small-molecule therapeutics for autoimmune, cancer, fibrotic, and central nervous system diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyROCK2 inhibitorsmall-molecule therapeuticsdrug discoveryclinical-stage biotechfibrotic diseaseautoimmune diseasemetabolic diseaseCNS disordersdrug licensingblood-brain barrierpharma partnershipbiotech startupdrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Graviton BioScience Comparables

Compare Graviton BioScience with similar companies based on industry and business-model similarity.

Graviton BioScience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ovid Therapeutics Inc.
82%
Genosco
81%
Sino Biopharmaceutical
78%

Graviton BioScience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BFeb 14, 2024
Series BNov 22, 2023
Series AMay 1, 2023
SeedFeb 19, 2021

Graviton BioScience Investors

Notable investors and investment history

Graviton BioScience investors
InvestorRounds
Enavate SciencesSeries A, Series B
Cormorant Asset ManagementSeries A
Pontifax Venture CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors grew 60% MoM, from 1.1K to 1.7K.

  • Nov 11, 2025

    Monthly visitors grew 41% MoM.

Graviton BioScience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Graviton BioScience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Graviton BioScience's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range48
Year Founded2020
Last FundingFeb 14, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?